Skip to main content

Table 2 The prevalence of comorbidities at the time of admission occurring in 5% or more of patients

From: Prevalence of medication-related falls in 200 consecutive elderly patients with hip fractures: a cross-sectional study

 

Whole population

Patients without a medication-related fall

Patients with a medication-related fall

P value (patients with vs. without a medication-related fall)

n (%)

200 (100)

118 (59)

82 (41)

 

Prevalence of comorbidity (n(%))

 Hypertension

90 (45)

49 (42)

41 (50)

0.2

 Osteoporosis

46 (23)

28 (24)

18 (22)

0.8

 Atrial fibrillation

44 (22)

21 (18)

23 (28)

0.09

 Previous ischaemic stroke

36 (18)

21 (18)

14 (17)

0.9

 Chronic obstructive pulmonary disease

32 (16)

16 (13)

16 (19)

0.2

 Dementia

30 (15)

15 (13)

15 (18)

0.3

 Previous fracture (hip or spine)

29 (14.5)

12 (10)

17 (20)

0.04

 Ischaemic heart disease

27 (13.5)

11 (9)

20 (24)

0.04

 Type 2 diabetes

27 (13.5)

19 (14)

8 (10)

0.4

 Chronic renal failure

25 (12.5)

16 (13)

9 (11)

0.6

 Depression

22 (11)

9 (7)

13 (16)

0.07

 Cancer

18 (9)

12 (10)

6 (7)

0.5

 Chronic heart failure

14 (7)

10 (8)

4 (5)

0.3

 Visual or hearing impairment

14 (7)

13 (7)

10 (7)

0.9

 Hyperthyreosis

12 (6)

7 (6)

5 (6)

1

 Arthrosis

12 (6)

6 (5)

5 (6)

0.7

 Hypothyreosis

10 (5)

6 (5)

4 (5)

1

 Chronic alcoholism

10 (5)

5 (4)

4 (5)

1

  1. Table 2. Comorbidities at the time of admission with a prevalence of 5 % or higher. One patient could have several diagnoses. Differences between patients with and without a medication-related fall were tested by the two-sample z-test